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We are exposed to a growing number of chemicals in
our environment, most of which have not been char-
acterized in terms of their toxicological potential or
mechanisms. Here, we employ a chemoproteomic
platform to map the cysteine reactivity of environ-
mental chemicals using reactivity-based probes to
mine for hyper-reactive hotspots across the prote-
ome. We show that environmental contaminants
such as monomethylarsonous acid and widely used
pesticides such as chlorothalonil and chloropicrin
possess common reactivity with a distinct set of pro-
teins. Many of these proteins are involved in key
metabolic processes, suggesting that these targets
may be particularly sensitive to environmental elec-
trophiles. We show that the widely used fungicide
chlorothalonil specifically inhibits several metabolic
enzymes involved in fatty acid metabolism and ener-
getics, leading to dysregulated lipid metabolism in
mice. Our results underscore the utility of using reac-
tivity-based chemoproteomic platforms to uncover
novel mechanistic insights into the toxicity of envi-
ronmental chemicals.
INTRODUCTION
Many complex human diseases cannot be explained by genetics
alone and likely have environmental or gene-environment causes
(Hemminki et al., 2006; Hunter, 2005). We are exposed to an
ever-growing number of chemicals, many of which have been
linked to adverse health effects, and most of which have not
been characterized in terms of their toxicological potential or
mechanisms (Bookman et al., 2011; Rappaport, 2011). It is
therefore likely that there are more chemicals in our environment
than previously anticipated that act as potential drivers of dis-
ease. These agents may go unnoticed due to adverse health ef-
fects that occur through yet unknown mechanisms.
While there have been many efforts made to characterize the
toxicology of environmental chemicals, ranging from traditional
long-term toxicity assessments in animal models and human1394 Chemistry & Biology 22, 1394–1405, October 22, 2015 ª2015 Eepidemiological studies to high-throughput screening and mod-
ern systems biology approaches to map gene and protein
expression changes, these approaches are often correlative or
provide insufficient detail on toxicological mechanisms (Bucher,
2013; Collins et al., 2008; Dix et al., 2007; Huang et al., 2011;
Shukla et al., 2010), because gene and protein expression,
epigenetic, or metabolite changes that manifest as cellular and
systemic phenotypes arising from chemical exposure are indi-
rect outcomes that result from direct chemical interactions
with specific molecular targets. Deconvoluting these indirect
effects to predict the direct molecular targets has been very
challenging. We believe that understanding the direct chemi-
cal-protein interactions of environmental chemicals is critical in
informing our understanding of downstream molecular events
and linking them to pathological effects, providing a direct
approach to identifying environmental drivers of disease.
Of particular concern among chemicals in our environment are
reactive electrophiles to which we are directly exposed or that
form through bioactivation (Rappaport et al., 2012). These envi-
ronmental electrophiles have the potential to covalently react
with nucleophilic amino acid hotspots within the proteome, lead-
ing to protein dysfunction and subsequent pathological effects
(Rappaport et al., 2012). These ‘‘hyper-reactive’’ nucleophilic
hotspots include cysteine, serine, and lysine residues that
are often involved in important biological functions such as catal-
ysis, regulation, post-translational modifications, redox balance,
metal binding, and protein-protein interactions (Shannon and
Weerapana, 2015). Although we are exposed to a large array
of potentially reactive chemicals, we have little to no understand-
ing regarding their interactions with hyper-reactive proteome
hotspots and the resulting effects on protein function, down-
stream biochemistry, or ensuing pathophysiological conse-
quences. While there have been many innovative approaches
to test the mutagenicity of DNA-damaging reactive electrophiles
(Araya and Fowler, 2011; Meier and Gartner, 2014), there
has been a considerable lag in technologies that enable
global assessment of chemical reactivity with the proteome. At
present there is a major gap in our knowledge of how reactive
chemicals elicit adverse health effects through chemical-protein
interactions.
Historically, the toxicological mechanisms underlying many
reactive electrophiles have been thought to occur through indis-
criminate covalent modifications on proteins or DNA leading to
mutations or non-specific toxicities. However, recent studieslsevier Ltd All rights reserved
have revealed that even highly reactive endogenous electro-
philes preferentially and selectively react with certain sites on
specific protein targets, indicating that the interactions of elec-
trophilic compounds with the proteome are driven not only
by their reactivity but also by their affinity to certain protein
microenvironments (Codreanu et al., 2014; Wang et al., 2014;
Weerapana et al., 2008, 2010). Here, we have employed a che-
moproteomic platform that uses reactivity-based probes to
comprehensively map the proteome-wide targets of reactive
environmental chemicals in complex biological systems. We
show that certain environmental chemicals show specific reac-
tivity with a set of previously unrecognized protein targets,
particularly enriched in enzymes that play key roles in meta-
bolism. Taking the widely applied fungicide chlorothalonil
(CTN) as a representative example, we use this reactivity-based
chemoproteomic platforms to directly identify specific enzymes
and transporters involved in fatty acid metabolism and ener-
getics as in vivo targets of CTN in mice, leading to distinct down-
stream biochemical alterations in the lipidome.
RESULTS AND DISCUSSION
Using Reactivity-Based Probes to Map Proteome-Wide
Interactions of Environmental Chemicals
Among amino acid side chains that may be adducted by reactive
electrophiles, cysteines are particularly sensitive to modification
due to their inherent nucleophilicity (Pace andWeerapana, 2013;
Shannon and Weerapana, 2015; Weerapana et al., 2010). This
nucleophilicity can be enhanced by local protein microenviron-
ments that lower the inherent pKa of certain cysteines (Poole,
2015). These hyper-reactive cysteines have been previously
shown to be important in diverse protein functions, including
catalysis, redox balance, protein-protein interactions, metal
binding, and functional regulation (Wang et al., 2014;Weerapana
et al., 2010). Weerapana et al. (2008, 2010) described a powerful
chemoproteomic platform that utilized a bioorthogonal cysteine-
reactive probe, iodoacetamide-alkyne (IAyne), to globally profile
these hyper-reactive cysteines across thousands of protein tar-
gets directly in complex proteomes. They showed that hyper-
reactive cysteines identified by this method were highly enriched
in sites important to protein function, indicating that this strategy
could be used to assess proteome-wide hyper-reactive and
functional sites (Wang et al., 2014; Weerapana et al., 2010).
In this study, we set out to address the knowledge gap in reac-
tive chemical toxicities and to identify potentially novel mecha-
nisms of action by mapping the proteome-wide interactions of
a representative and diverse set of highly used reactive environ-
mental electrophiles. We adapted the chemoproteomic strategy
put forth by Weerapana et al. (2010), whereby we competed
these chemicals against the binding of the cysteine-reactive
IAyne probe to hyper-reactive sites in native tissue proteomes
(Figures 1A–1C). We have employed two complementary strate-
gies to achieve this goal: a gel-based fluorescence assay for
rapid chemical screening and a proteomic-based approach for
detailed target identification. In brief, we treated proteomes
with a panel of representative reactive environmental chemicals
to allow covalent binding to sensitive sites. Proteomes were then
treated with the cysteine-reactive probe IAyne to competitively
label available hyper-reactive cysteines, followed by appendingChemistry & Biology 22, 1394–1an azide-linked rhodamine or biotin enrichment handle using
copper-catalyzed azide-alkyne cycloaddition or ‘‘click chemis-
try,’’ for fluorescent or proteomic-based detection, respectively.
Fluorescently tagged proteomes were separated by SDS-PAGE,
and biotin-tagged proteomes were enriched and digested to
tryptic peptides for liquid chromatography-tandem mass spec-
trometry (LC-MS/MS)-based proteomic analyses. We then
determined the reactivity of the environmental chemicals by
either loss of fluorescent labeling or loss of MS signal.
We tested representative classes of widely used or commonly
exposed reactive environmental chemicals, including metals,
chemical breakdown products, and several pesticide classes,
for their concentration-dependent cysteine reactivity in mouse
liver and kidney proteomes against IAyne labeling of cysteine-
reactive sites. Using the gel-based detection method, we
observed dose-dependent reactivity of certain chemicals such
as monomethylarsonous acid (MMA), a highly toxic bioactivated
arsenical (Watanabe and Hirano, 2013); hydroquinone (HQ), a
bioactivated metabolite of benzene (McHale et al., 2012); the
widely used fungicide CTN (Wilkinson and Killeen, 1996); and
the broad-spectrum pesticide chloropicrin (Oriel et al., 2009)
(Figures 1D and S1). In contrast, chemicals such as the chloroa-
cetanilide herbicide acetochlor, the organophosphorus insecti-
cide chlorpyrifos oxon (CPO), and the common industrial
chemical and food contaminant acrylamide showed little to no
observable reactivity at the tested concentrations (Figures 1D
and S1). These seemingly unreactive chemicals may still bind
to protein targets, but their reactivity may be masked in gel-
based approaches or they may target other amino acid hotspots
in the proteome. For example, our previous studies using activ-
ity-based protein profiling have shown that CPO and triphenyl
phosphate (TPP) react with the catalytic serines of several serine
hydrolases (Medina-Cleghorn et al., 2014; Morris et al., 2014;
Nomura et al., 2005, 2008, 2011). Alternatively, these chemicals
may not form stable protein adducts, may be rapidly oxidized by
detoxifying enzymes, or may react with other non-protein biolog-
ical nucleophiles such as glutathione or nucleic acids.
To identify the direct protein targets of the chemicals that
showed reactivity by our gel-based detection methods, we first
applied our LC-MS/MS-based competitive chemoproteomic
analysis to MMA, CTN, and chloropicrin at 100 mM in vitro in
mouse liver proteomes (Figure 2A and Table S1). Based on liter-
ature and chemical properties, these chemicals were deter-
mined as likely to directly and covalently interact with protein
targets in complex proteomes when compared with potentially
indirect mechanisms of HQ such as generation of oxidative
stress. Out of 339 total targets enriched by IAyne labeling
(>5 spectral counts, >2-fold above no-probe DMSO controls),
we found that CTN, MMA, and chloropicrin interact with 37,
69, and 119 protein targets, respectively (Figure 2B and Table
S1). First, we note that by using this chemoproteomic approach,
we were able to enrich cysteine-reactive protein targets across
hundreds of proteins spanning diverse protein classes (Table
S1). Second, while each reactive agent shows a distinct protein
target profile, CTN, MMA, and chloropicrin collectively bind 31
protein targets in common, spanning many unrelated protein
classes that include metabolic enzymes, cell-structure proteins,
chaperones, and translation-related proteins. Third, we also
show that the targets of individual chemicals are not merely405, October 22, 2015 ª2015 Elsevier Ltd All rights reserved 1395
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Figure 1. Mapping Proteome-Wide Interactions of Reactive Environmental Chemicals Using Reactivity-Based Probes and Chemoproteomic
Profiling
(A–C) Herewemapped the direct chemical-protein interactions of reactive environmental chemicals, includingmetals (MMA), chemical breakdown products (HQ,
acrylamide), and pesticides (CTN, acetochlor, chloropicrin, CPO) directly in complex proteomes.We employed a gel-based fluorescence assay for screening and
a proteomic approach for target identification. Proteomes were pre-treated with either vehicle or environmental electrophiles, competitively labeled with the
cysteine-reactive iodoacetamide-alkyne (IAyne) probe, after which an azide-linked rhodamine or biotin enrichment handle was appended using ‘‘click chemistry’’
for fluorescent or proteomic detection, respectively. Fluorescently tagged proteomes were separated by SDS-PAGE, and biotin-tagged proteomes were en-
riched and digested to tryptic peptides for liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomic analyses. Reactivity of environ-
mental chemicals was determined by loss of fluorescent labeling or MS signal.
(D) Gel-based analyses of environmental chemical reactivity with cysteine-reactive sites on proteins in mouse liver proteomes. Proteomes were pre-treated
in vitro with chemicals at the designated concentrations (30 min) and then competed with IAyne labeling (10 mM, 60 min), rhodamine conjugation, and cysteine
reactivity visualized by SDS-PAGE and in-gel fluorescence. The gel-based analyses reveal the substantial cysteine reactivity of MMA, HQ, CTN, and chloropicrin.
Shown are representative gels from n = 3. Cysteine reactivity in kidney is shown in Figure S1.
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Figure 2. Target Identification of Reactive Environmental Chemicals
(A) Competitive chemoproteomic analysis for direct protein target identification of CTN, MMA, and chloropicrin (reactive chemicals from Figure 1D) was per-
formed using mouse liver proteome treated with vehicle or chemical (100 mM, 30 min) prior to IAyne labeling (10 mM, 30 min) or vehicle (no-probe control). Each
biological replicate uses a liver homogenate from a different 6-week-old male C57BL/6 mouse. Subsequent biotin conjugation, avidin enrichment of targets, and
analysis of trypsin-digested peptides by LC-MS/MS revealed enrichment of 339 total proteins by IAyne labeling spanning diverse protein classes (>5 spectral
counts, >2-fold above no-probe DMSO controls). Data are expressed as heatmaps showing ratios of treatment compared with control. IAyne-enriched targets
are sorted by their spectral counts.
(B) MMA, CTN, and chloropicrin significantly displace IAyne labeling of protein targets in vitro in mouse liver (p < 0.05 compared with vehicle-treated controls
using two-way ANOVA with Tukey’s multiple comparisons test). MMA, CTN, and chloropicrin possess 31 overlapping targets. Highlighted in red are metabolic
enzyme targets, and in bold red are those enzymes involved in lipid metabolism. Data are presented as mean ± SEM; n = 3 per group.
Raw proteomic data and statistical analyses are shown in Table S1. HQ targets are shown in Figure S2.
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restricted to the most abundant IAyne-enriched targets, but
instead span the entire range of detected protein abundances,
suggesting that these interactions result from a combination of
affinity and reactivity toward these targets and not just through
non-specific reactivity with the most abundant IAyne-enriched
targets (Figures 2A and 2B). Conversely, there are many high-
abundance IAyne-enriched proteins that were not bound by
CTN, MMA, or chloropicrin. Most of the targets of CTN, MMA,
and chloropicrin identified by our chemoproteomic approach
have not been previously identified as targets of these agents
(Figure 2B and Table S1). Interestingly, 19 of the 31 shared tar-
gets are enzymes involved in key metabolic processes (high-
lighted in red in Figure 2B), and six of these enzymes are involved
in different aspects of lipid metabolism (in red and bold in Fig-
ure 2B). Hmgcs2, Acaa1b, Acsf2, and Acox2 are all involved in
energetic fatty acid oxidation, Acly is involved in producing
acetyl-coenzyme A (CoA) for de novo lipogenesis, and Aldh1a1
catalyzes the oxidation of retinaldehyde to form the critical
signaling molecule retinoic acid (Kanehisa and Goto, 2000).
These agents binding covalently to reactive nucleophiles on their
target enzymesmay disrupt lipid metabolism in particular, repre-
senting a novel mechanism of toxicity not previously associated
with these chemicals. Thus, we show that structurally dissimilar
reactive environmental chemicals share certain specific and
overlapping targets predominantly involved in metabolism.
These protein targets may be particularly susceptible to disrup-
tion by environmental electrophiles, and exposure to multiple
agents may synergistically affect protein function to exert signif-
icant toxicities.
In addition to CTN, MMA, and chloropicrin, we also profiled
HQ and acrylamide reactivity at 100 mM in mouse liver proteome
in vitro. We identified 12 protein targets of HQ, most of which do
not overlap with those of CTN, MMA, and chloropicrin (Figure S2
and Table S1). This lack of overlap may be due to the indirect
mechanism of HQ in generating reactive oxygen stress that
may be leading to cysteine oxidation (Kalf, 1987), compared
with the potentially covalent reactive mechanisms of CTN,
MMA, and chloropicrin. Consistent with the gel-based ap-
proaches, we observed no direct targets of acrylamide (Table
S1). It is possible that this apparent lack of HQ and acrylamide
reactivity may be due to insufficient concentration or the need
for bioactivation, or that these compounds are rapidly oxidized
by detoxifying enzymes, may form transient or unstable protein
adducts, or may react with other biological nucleophiles. We
also note the possibility that we may be masking hyper-reactive
cysteines present in living cells that may become oxidized during
tissue proteome preparation.
CTN Shows Selective Reactivity with Protein Targets
In Vivo in Mouse Kidney
Building on our in vitro profiling, we next wanted to validate our
chemoproteomic strategy using an in vivo model of exposure
in mice. We treated mice with the maximally tolerated doses of
CTN, MMA, HQ, acrylamide, and chloropicrin at 100, 1, 50,
100, and 4mg/kg intraperitoneally (i.p.), respectively, and subse-
quently labeled liver and kidney proteomes ex vivo with IAyne
to detect in vivo cysteine reactivity (Figure 3A). While we did
not observe reactivity using gel-based methods in liver, CTN
showed considerable in vivo reactivity in mouse kidney (Fig-1398 Chemistry & Biology 22, 1394–1405, October 22, 2015 ª2015 Eure 3A). We thus selected CTN for further study. CTN is one
of the most widely used pesticides, with 9 million pounds
(4million kg) applied per year in United States agriculture alone
(Grube et al., 2011). Despite its heavy usage, CTN has also been
shown to cause renal toxicity and kidney carcinogenesis in mul-
tiple animal models, although the underlying toxicological mech-
anisms remain poorly understood (Wilkinson and Killeen, 1996).
Thus, our finding that CTN showed selective reactivity in mouse
kidney compared with liver was interesting (Figure 3A).
Encouraged by these results, we conducted a comprehensive
assessment of CTN reactivity in vivo inmouse liver and kidney by
developing a tailored bioorthogonal probe, CTNyne (Figures 3B
and S3). The CTNyne probe is a structural analog of CTN that
contains a bioorthogonal alkyne handle for click chemistry
conjugation after labeling in proteomes. We competitively
labeled liver and kidney proteomes from mice treated in vivo
with vehicle or CTN with the CTNyne probe, and appended
a rhodamine reporter for in-gel fluorescence analysis. We
confirmed that CTNyne labels multiple targets in kidney, and
that many of these targets were competed by in vivo CTN treat-
ment, demonstrating the increased specificity for CTN targets
using the CTNyne probe (Figure 3C). While CTNyne labeled
many protein targets in liver, most of these targets were not dis-
placed by in vivo CTN treatment, recapitulating our previous
observation with IAyne labeling (Figure S3).
CTN Affects Metabolic Enzymes Involved in Energetics
and Fatty Acid Metabolism
Based on the findings from our in-gel fluorescence analysis, we
next sought to identify the in vivo targets of CTN inmouse kidney
using our CTNyne probe and gain mechanistic insight into CTN
toxicity. We used the kidney proteomes of mice exposed in vivo
to vehicle or CTN for an ex vivo competitive labeling by our
CTNyne probe, followed by LC-MS/MS-based chemoproteomic
analysis. Through this approach, we identified 216 protein tar-
gets that were significantly enriched by the CTNyne probe
compared with no-probe controls (Figure 3D and Table S2).
From these enriched proteins, we identified 44 targets that
were significantly competed by in vivo CTN treatment more
than 2-fold and were detected at >20 spectral counts in abun-
dance (Figure 3E and Table S2). In contrast to our findings in
mouse kidney in vivo, we identified only five in vivo targets in
mouse liver (Figure S3 and Table S2).
Of the 44 in vivo kidney targets of CTN that we identified, we
were intrigued to find that a substantial proportion of these tar-
gets (19 proteins) were enzymes involved in the metabolism of
small-molecule metabolites (red emphasis, Figure 3E). The ma-
jority of these enzymes (12 targets) are involved in energetics,
participating in glycolytic, gluconeogenic, or fatty acid metabolic
pathways (bold red emphasis in Figure 3E). These enzymes
include the glycolytic enzymes glyceraldehyde-3-phosphate
dehydrogenase (Gapdh), triosephosphate isomerase 1 (Tpi1),
and lactate dehydrogenases (Ldha, Ldhb), and the gluconeo-
genic enzymes fructose-1,6-bisphosphatase 1 (Fbp1) and pyru-
vate carboxykinase 1 (Pck1). Enzyme targets involved in fatty
acid transport or oxidation include fatty acid transport protein
2 (Fatp2), 3-ketoacyl-CoA thiolase 1b and 2 (Acaa1b and
Acaa2), peroxisomal acyl-CoA oxidase 1 (Acox1), and carnitine
palmitoyltransferase 1a (Cpt1a), as well as the ketonelsevier Ltd All rights reserved
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Figure 3. CTN Binds Metabolic Enzymes In Vivo Involved in Energetics and Fatty Acid Metabolism
(A) Reactivity of CTN, MMA, HQ, acrylamide, and chloropicrin was assessed by in vivo treatment in mice (at maximum tolerated dose of 100, 1, 50, 100, and
4 mg/kg i.p., 2 hr), and subsequent labeling of liver and kidney proteomes with IAyne (10 mM, 30 min) and visualization of cysteine-reactive targets by SDS-PAGE
and in-gel fluorescence. CTN reactivity in vivo is displayed through displacement of IAyne binding ex vivo, indicated by ‘‘>’’ signs.
(B) We developed a tailored bioorthogonal probe, CTN-alkyne (CTNyne), to comprehensively identify mouse in vivo CTN targets in the relevant organ, kidney.
(legend continued on next page)
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body-generating enzyme 3-hydroxymethyl-3-methylglutaryl-
CoA lyase (Hmgcl). Collectively, our results indicated that CTN
might alter renal energetics and fatty acid metabolism.
To validate these metabolic enzymes as true CTN-specific
hits, we recombinantly overexpressed representative targets
from each pathway in HEK293T cells and subsequently per-
formed in vitro competition studies with CTN against IAyne
or CTNyne labeling. Indeed, we show that Acaa1b, Acaa2,
Gapdh, Hmgcl, and Pck1 were labeled by IAyne, and this label-
ing was displaced in a concentration-dependent manner by
CTN, indicating that CTN specifically bound to one or more hy-
per-reactive cysteine on these proteins (Figure 4A). While we
found that CTN displaced binding of CTNyne to Fatp2 (Fig-
ure 4A), Fatp2 was not labeled by IAyne (data not shown), sug-
gesting that CTN may bind to another hyper-reactive residue
on this protein besides cysteine. We calculated 50% inhibitory
concentration (IC50) values of 0.9–24 mM for CTN binding to
Acaa1b, Acaa2, Gapdh, Hmgcl, Pck2, and Fatp2 (Figure 4A).
We note that the IC50s are a rough estimate of relative reac-
tivity, since the reaction is covalent and there is no equilibrium.
Furthermore, we demonstrate that CTN is binding to catalytic
cysteines on key energetic enzymes through blunted or elimi-
nated IAyne labeling upon mutagenesis of Acaa2 and Gapdh
catalytic cysteines to C92A and C150A, respectively (Figures
4B and S4).
Although we were unsuccessful at recombinantly overex-
pressing Cpt1a, we confirmed that the endogenous kidney
carnitine palmitoyltransferase activity from in vivo CTN-treated
mice was significantly inhibited compared with vehicle-treated
controls, as measured by an activity assay using trimethyl-d9-
L-carnitine and C16:0 free fatty acid (C16:0 FFA) substrates
measuring C16:0-trimethyl-d9-carnitine product formation by
LC-MS/MS (Figure 4C). We also wanted to determine whether
CTN inhibits the activity of Fatp2, an enzyme with both peroxi-
somal fatty acyl-CoA synthetase activity and cytosolic fatty
acid transport activity (Falcon et al., 2010). We indeed show
that acyl-CoA synthetase activity was completely inhibited in
the kidneys of mice treated in vivo with CTN compared with
vehicle-treated controls, as measured by an activity assay using
[U-13C]C16:0 FFA substrate and measuring [U-13C]C16:0 fatty
acyl-CoA (FA-CoA) product formation by single-reaction moni-
toring (SRM)-based LC-MS/MS (Figure 4D). Next, to determine
whether fatty acid transport might be impaired in vivo due to in-
hibition of Fatp2, we performed an in vivo isotopic fatty acid
tracing study and showed that i.p. administered isotopically
labeled [U-13C]C16:0 FFA incorporation into representative
complex lipids in mouse kidney was significantly lower in CTN-
treated mice, including isotopically labeled species of acyl carni-
tine, lysophosphatidylcholine, and triacylglycerols (Figure 4E).(C) CTNyne labels multiple protein targets in mouse kidney (10 mM, 30 min), and
(D and E) In vivo CTN-specific protein targets were identified by labeling in vivo ve
followed by biotin conjugation, avidin enrichment, and tryptic peptide analysis by
probe compared with no-probe control. Data are presented as a heatmap of total
control for each protein. (E) 44 proteins were identified as CTN targets that were >
competed >2-fold by in vivo CTN treatment. 19 of these targets are metabolic enz
fatty acid metabolic pathways (bold red emphasis).
Data in (A) and (C) are representative gels from n = 3–4 mice/group. Data in (D) an
Data in (E) are presented as mean ± SEM, n = 3 per group. In vivo liver targets o
1400 Chemistry & Biology 22, 1394–1405, October 22, 2015 ª2015 EWhile we cannot directly attribute these activities to Fatp2, these
data taken together suggest that fatty acid transport and acyl-
CoA synthetase activities attributable to Fatp2 are inhibited
in vivo by CTN in the kidney.
We next wanted to assess the downstream biochemical ef-
fects that may arise from inhibition of the metabolic enzyme tar-
gets of CTN, especially those involved in fatty acid metabolism.
We performed SRM-based LC-MS/MS metabolomic analyses
on kidneys from mice treated in vivo with CTN to identify alter-
ations in the lipidome conferred by CTN treatment. Consistent
with our results suggesting that CTN disrupts fatty acid transport
both into cells through Fatp2 inhibition and into mitochondria
through Cpt1a inhibition, and causes impairments in fatty acid
oxidation, we observe expected increases in FFA levels and de-
pletions in the levels of FA-CoAs (Fatp2 and b-oxidation prod-
ucts) and acyl carnitines (Cpt1a product) in mouse kidney from
in vivo CTN treatment (Figures 4E and S4; Table S3). CTN has
previously been shown to react directly with glutathione, causing
glutathione depletion and toxicity (Wilkinson and Killeen, 1996).
However, we show that, at the doses used here, both liver and
kidney glutathione levels were unchanged upon CTN administra-
tion (Figure S4).
Collectively, we show that the major fungicide CTN inhibits
metabolic enzymes in kidney that are involved in energetic meta-
bolism, leading to downstream biochemical alterations in glycol-
ysis and fatty acid metabolism.Conclusions
Here, we have used a chemoproteomic platform employing
reactivity-based chemical probes to map the proteome-wide in-
teractions of environmental chemicals and uncover novel mech-
anisms through which these chemicals may cause adverse
health effects. We show here that individual environmental elec-
trophiles engage specific protein targets with privileged reac-
tivity, and do not non-specifically target all proteins or merely
react with the most abundant targets. This indicates that these
agents possess affinities to highly reactive nucleophiles on spe-
cific proteins, suggesting that the mechanisms of toxicity may
be through interactions with these selected proteins to cause
distinct downstream adverse biochemical events. By competing
these chemicals against a cysteine-reactive probe, we show that
seemingly dissimilar reactive environmental agents including the
fungicide CTN, the arsenical MMA, and the insecticide chloro-
picrin possess both distinct and overlapping targets in the prote-
ome, suggesting that these protein targets may be particularly
susceptible to reactive electrophiles. It will be of future interest
to examine whether prolonged or combined exposure to these
and other reactive chemicals causes sustained and cumulativeis displaced by in vivo CTN treatment (100 mg/kg i.p., 2 hr).
hicle- and CTN-treatedmouse kidney proteomes with CTNyne (50 mM, 30min),
LC-MS/MS. (D) 216 protein targets were significantly enriched by the CTNyne
CTNyne-enriched targets normalized to the average spectral counts of CTNyne
20 spectral counts in abundance and significantly (p < 0.05 by two-tailed t test)
ymes (red emphasis), 12 of which are involved in glycolytic, gluconeogenic, or
d (E) are from n = 3–4 mice/group; raw proteomic data are shown in Table S2.
f CTN are shown in Figure S3.
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Figure 4. CTN Inhibits the Activity of Several Metabolic Enzymes Involved in Energetics and Fatty Acid Metabolism Leading to Dysregulated
Lipid Metabolism
(A) Representative metabolic enzyme targets of CTN in vivo in mouse kidney were validated by recombinant target overexpression in HEK293T and COS7 cells.
Lysates from mock- or target-overexpressing cells were pre-incubated with vehicle or 0.01–100 mM CTN (30 min), followed by labeling with IAyne or CTNyne
(10 mM, 30 min). 50% inhibitory concentration (IC50) values are reported.
(B) CTN binds the catalytic cysteine on Acaa2 (C92) and Gapdh (C150), as confirmed by CTN-sensitive IAyne labeling of Acaa2, and Gapdh is substantially lower
in Acaa2 C92A and Gapdh C150A-overexpressing compared with wild-type (wt) Acaa2 and Gapdh-overexpressing HEK293T lysates. Expression controls for
wild-type and mutant enzymes are shown in Figure S4, ascertained by qPCR analysis of RNA harvested alongside these experiments showing equivalent
expression.
(C and D) Carnitine palmitoyltransferase (C) and fatty acyl-CoA synthetase (D) activity are significantly inhibited in in vivo CTN-treated (100mg/kg i.p., 2 hr) mouse
kidney proteomes compared with vehicle-treated controls. Carnitine palmitoyltransferase activity was assessed ex vivo using C16:0 free fatty acid (FFA) and
trimethyl-d9-L-carnitine measuring C16:0-d9-carnitine formation by SRM-based LC-MS/MS. Acyl-CoA synthetase activity was assessed ex vivo using
[U-13C]C16:0 FFA and CoA, measuring [U-13C]C16:0-CoA formation by SRM-based LC-MS/MS.
(legend continued on next page)
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adduction of these common targets, leading to adverse
biochemical and pathophysiological effects.
We note that the other reactive environmental chemicals we
screened that did not show cysteine reactivity by our gel-based
fluorescence method may still react with protein targets. These
chemicals may potentially bind to hyper-reactive cysteines on
particular targets that are simply poorly resolved by SDS-
PAGE, may bind at even higher concentrations, or may bind to
other hyper-reactive amino acid side chains. For example, while
the flame retardant TPP and the bioactivated insecticide metab-
olite CPO do not show cysteine reactivity, we have previously
shown that these chemicals covalently bind to and inhibit cata-
lytic serines of several serine hydrolases (Medina-Cleghorn
et al., 2014; Morris et al., 2014; Nomura et al., 2008; Nomura
and Casida, 2011). Nonetheless, the enzyme targets that we
identify here represent multiple, potentially novel mechanisms
of toxicity that may even be in common across broad classes
of environmental electrophiles. We also note that we may still
be missing some direct protein targets of the chemicals that
we showcase in this study. The cysteine-reactive probe may
be labeling multiple sites on each protein, and thus we may be
obscuring chemical-protein interactions when we quantify en-
riched proteins based on total peptides for each protein. In addi-
tion, certain chemicals may also require bioactivation in specific
tissues in vivo before they may bind highly reactive nucleophilic
residues. It will be of future interest to complement our studywith
a more comprehensive quantitative proteomics approach for
identifying sites of probe modification and sites of chemical
displacement of probe binding.
We also demonstrate the ability to apply the chemoproteomic
strategies described in this study to assess in vivo reactivity of
environmental chemicals, which enables assessment of target
organs that may be particularly susceptible to toxicity from envi-
ronmental agents. Using the fungicide CTN as an example, we
showed that CTN exhibits particular reactivity with protein tar-
gets in vivo in mouse kidney compared with liver. Through the
compound-specific CTNyne probe, we identified 44 direct pro-
tein targets of CTN in vivo in mouse kidney. We found that this
target list was enriched in metabolic enzymes involved in glyco-
lytic and fatty acid metabolism and that the activities of these
enzymes were seemingly inhibited. Through subsequent metab-
olomic profiling, we observed a dysregulation of lipid meta-
bolism, consistent with our target list. The inhibition of glycolytic
and gluconeogenic metabolism, fatty acid transport, and fatty
acid oxidation enzymes, potentially leading to altered levels of
key metabolites and perturbed metabolic networks, represents
a novel mechanism of toxicity for CTN.
While the doses of CTN used in this study to identify direct
in vivo targets were high, the apparent IC50 values of CTN against
the targets that we have validated here are within an order of(E) Isotopic incorporation of [U-13C]C16:0 FFA into complex lipids in vivo in kidn
vehicle or CTN (100 mg/kg i.p., 1 hr), followed by [U-13C]C16:0 acid (100 mg/kg i.p
(F) Consistent with inhibition of CTN target fatty acid transport and oxidation e
decreased C14:0 and C16:0 fatty acyl-CoA (FA-CoA), and decreased C12:0 acy
Data in (A) and (B) are representative gels from n = 3/group. Data in (C–E) are p
*p < 0.05 compared with vehicle-treated controls using two-tailed tests. Data in
abundances in two independent experiments. Rawmetabolomic data are shown
Figure S4.
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in human serum. Barr et al. (2010) previously reported up to
25 ng/g of CTN found in human maternal and cord sera, which
equates to 100 nM. Acaa2, Acaa1b, Gapdh, Fatp2, and Pck1
showed 9.4% ± 1.2%, 3.4% ± 3.4%, 20% ± 8.4%, 13% ±
6.7%, and 6.8%±6.8% reduction, respectively, in IAyne labeling
compared with vehicle-treated controls. Acaa2 and Gapdh were
significantly inhibited (p < 0.05 compared with vehicle-treated
controls using a two-tailed t test) at 100 nM.
Indeed, studies in animal models have linked CTN to selective
kidney toxicity and carcinogenesis, although the mechanisms
have remained unclear (Wilkinson and Killeen, 1996). Here, we
suggest that the kidney-specific toxicity of CTN may be due to
the inhibition of energetic and fatty acid metabolism enzymes,
which may impair cell function, causing cellular necrosis and
subsequent kidney dysfunction. When considered in the
context of chronic exposure, these toxicities may develop into
pathophysiologies such as inflammation, fibrosis, and cancer.
Because CTN presumably acts through covalent modification
of these targets, cumulative exposure may cause an accumula-
tion of protein adducts on these targets, leading to their eventual
inhibition.
While we have identified novel potential toxicological mecha-
nisms of CTN, we still do not understand the basis for the
observed selective reactivity of CTN in kidney compared with
liver. Previous studies have postulated that CTN may cause kid-
ney-specific toxicity through glutathione conjugation and further
bioactivation by b-lyase, an enzyme highly expressed in renal
proximal tubules (Wilkinson and Killeen, 1996). Thus, while we
show here that CTN itself directly interacts with the observed
in vivo CTN targets, CTN may also undergo further kidney-spe-
cific bioactivation to inhibit the observed targets. It will be of
future interest to investigate the role of CTNmetabolites in inhib-
iting the CTN targets, and perform long-term and low-dose
chronic treatment studies to determine whether CTN may cause
renal toxicity or carcinogenesis through inhibiting these targets.
Many of the metabolic enzyme targets inhibited by CTN and
other reactive agents used this study involve active-site cyste-
ines that directly contribute to the catalytic mechanisms. For
example, Gapdh uses the active-site cysteine to form a hemi-
thioacetal intermediate, and many of the fatty acid oxidation
enzymes (e.g. Acaa1b and Acaa2) form thioester intermediates
using their active-site cysteines (Mathieu et al., 1997; Poirier
et al., 2006; Seidler, 2013). The enrichment of metabolic en-
zymes among the observed targets may suggest that enzymes
that use cysteines in their mechanism are particularly suscepti-
ble to reactive environmental electrophiles.
In this study, we have demonstrated that chemoproteomic
profiling using reactivity-based probes enables the mapping of
direct proteome-wide interactions of reactive environmentaley was measured ex vivo by SRM-based LC-MS/MS from mice treated with
., 1 hr). AC, acyl carnitine; LPC, lysophosphatidylcholine; TAG, triacylglycerols.
nzymes, in vivo CTN treatment (100 mg/kg i.p., 2 hr) leads to elevated FFA,
l carnitine levels in mouse kidney, compared with vehicle-treated controls.
resented as mean ± SEM; n = 3–5 mice/group. Significance is presented as
(F) show fatty acid-derived metabolites with significantly (*p < 0.05) altered
in Table S3 and a more detailed overview of the metabolomics data is shown in
lsevier Ltd All rights reserved
chemicals, which provides mechanistic detail for downstream
toxicities. We also show that metabolomic profiling can be
coupled with chemoproteomic-based target identification to
help demonstrate the biochemical outcomes associated with in-
teractions of these chemicals with specific protein targets. Look-
ing forward, we anticipate that metabolomics approaches will
enable identification of robust biomarkers of exposure and
toxicity for CTN and other environmental chemical agents.
Furthermore, we foresee that using chemoproteomic platforms
to screen emerging industrial, environmental, or pharmaceutical
chemicals against a suite of reactivity-based probes for other hy-
per-reactive amino acids will reveal potential off-targets and
toxicological liabilities early on in the development pipeline.
The advance knowledge of specific reactivities and detailed
mechanistic insights revealed by this approach can be used to
direct efforts toward optimizing the chemical structures and
ensuring the selectivity and safety of future chemicals.
SIGNIFICANCE
We are exposed to a growing number of chemicals in our
environment, most of which have not been characterized
in terms of their toxicological potential or mechanisms.
Research into understanding how chemicals may produce
adverse effects has primarily focused on DNA-mutating
or reversible endocrine-disrupting mechanisms, and has
largely ignored potential alternative toxicological mecha-
nisms arising from chemical interactions with the >20,000
protein targets in the human proteome. Particularly con-
cerning among chemicals in our environment are reactive
electrophiles that have the potential to covalently react
with amino acid hotspots and lead to protein dysfunction
and pathological effects. Here, we have used a reactivity-
based chemoproteomic platform to map the cysteine
reactivity of environmental chemicals, and show that con-
taminants such as monomethylarsonous acid and widely
used pesticides such as chlorothalonil and chloropicrin
possess common reactivity with a distinct set of sensitive
proteins. Many of these proteins are involved in key meta-
bolic processes, suggesting that these targets may be
particularly sensitive to environmental electrophiles. We
also show that the widely used fungicide chlorothalonil spe-
cifically inhibits several metabolic enzymes involved in fatty
acid metabolism and energetics, leading to dysregulated
lipid metabolism in mice. Our results highlight the utility of
using reactivity-based chemoproteomic platforms to un-
cover novel mechanistic insights into the toxicity of environ-
mental chemicals, and provide a potential framework for
testing emerging chemicals.
EXPERIMENTAL PROCEDURES
Mice
Male C57BL/6 mice (6–8 weeks old) were acutely (2 hr) exposed by i.p. injec-
tion to 100 mg/kg CTN (Tocris Bioscience) in a vehicle of 42:2.5:1:1 saline/
DMSO/emulphor/ethanol (10 ml/g mouse). For isotopic tracing studies, mice
were first exposed to 100 mg/kg CTN by i.p. injection for 1 hr, then exposed
to 100 mg/kg [12C]16:0 FFA (Sigma) or [U-13C]16:0 FFA (Cambridge Isotopes)
dissolved in undiluted PEG40 castor oil (Spectrum) by i.p. injection for 1 hr.
Following exposure, mice were euthanized by cervical dislocation, and liversChemistry & Biology 22, 1394–1and kidneys were immediately removed and flash-frozen in liquid nitrogen.
Animal experiments were conducted in accordance with the guidelines of
the Institutional Animal Care and Use Committee of the University of California,
Berkeley.
Processing of Mouse Brain, Liver, and Kidney Proteomes
Tissueswere homogenized inMg2+/Ca2+-free 13PBS (Corning Life Sciences),
followed by a 1,0003 g centrifugation of the homogenate. The resulting super-
natant was collected and used for subsequent assays. Protein concentrations
were determined by Bradford assay (Bio-Rad).
Cell Culture, Recombinant Overexpression, and Site-Directed
Mutagenesis
HEK293T and COS7 cells were cultured in DMEM media containing 10%
fetal bovine serum and maintained at 37C with 5% CO2. Recombinant
cDNA constructs containing enzymes of interest in the SPORT6 vector
were purchased from Thermo Open Biosystems and transiently transfected
into HEK293T (Acaa1b, Acaa2, Fatp2, Gapdh) cells using Fugene HD
(Promega) or into COS7 cells (Hmgcl, Pck1) using Lipofectamine 2000 (Life
Technologies). Site-directedmutagenesis was performed using aQuikChange
II XL kit (Agilent Technologies) and mutant plasmids were transiently trans-
fected into HEK293T cells. Further details can be found in Supplemental
Methods.
Electrophile Competition and Click Chemistry Procedures to
Append Analytical Handles to IAyne- or CTNyne-Treated Mouse
Proteomes
Proteome samples diluted in PBS (10, 25, or 50 mg in 50 ml of PBS for gel-based
analysis; 0.5 mg liver homogenate in 0.5 ml of PBS or 1 mg of kidney homog-
enate in 0.5 ml of PBS) were subjected to vehicle or electrophile treatment for
30 min at 37C. Then, IAyne (1 mM or 10 mM, gel-based assays; 10 mM, MS-
based assays; CHESS) or CTNyne (10 mM, gel-based assays; 50 mM, MS-
based assays) labeling was performed for 30 min (gel-based analysis) or
1 hr (MS-based analysis) at room temperature. Copper-catalyzed azide-alkyne
cycloaddition (click chemistry) was performed using previously described
methods (Nomura et al., 2010; Weerapana et al., 2010). Fluorescent and pro-
teomic detection of IAyne- or CTNyne-labeled bands were performed as pre-
viously reported (Nomura et al., 2010; Weerapana et al., 2010). Further details
can be found in Supplemental Methods.
Metabolomic Profiling
Metabolomic profiling was performed using previously reported procedures
(Benjamin et al., 2013). Additional details are reported in Supplemental
Methods.
Activity Assays
Carnitine palmitoyltransferase activity was assayed by incubating kidney
lysate from in vivo exposed mice at 10 mg in 400 ml of PBS with 100 mM
C16:0 FA-CoA lithium (Sigma-Aldrich) and 100 mM trimethyl-d9-L-carnitine
(Cambridge Isotopes) for 5 min at 37C. Reactions were quenched by addition
of 1.2 ml of 2:1 chloroform/methanol with dodecylglycerol (10 nmol, internal
standard) and mixed by vortexing. The organic layer was collected and dried
under a stream of N2 then resuspended in 120 ml of chloroform for SRM-based
LC-MS/MS analysis targeting palmitoyl-d9-trimethyl-carnitine, and analyzed
as previously described.
Acyl-CoA synthetase activity was assayed as using a modified protocol
based on Falcon et al. (2010). In brief, 5 mg of kidney lysate from mice treated
in vivo with CTN or vehicle were incubated in 200 ml of Tris-HCl (pH 8.5) buffer
containing 10 mM ATP (Sigma), 10 mM MgCl2 (Sigma), 200 mM CoA (Sigma)
and 10 mM [U-13C]16:0 FFA (Cambridge Isotopes) was added for 30 min at
37C. Reactions were quenched with 750 ml of Dole reagent (20:5:1 2-propa-
nol/n-heptane/2M H2SO4), vortexed, and dried under a stream of N2. The
product was then resuspended in a buffer of 4 ml of 2:1:1 chloroform/
methanol/PBS + 0.1% formic acid, containing 10 nmol of pentadecanoic
acid standard. The product was mixed by vortexing and the organic layer
was collected, dried under a stream of N2, resuspended in 120 ml of
chloroform, and analyzed by SRM-based LC-MS/MS analysis targeting
[U-13C]16:0 FA-CoA as previously described.405, October 22, 2015 ª2015 Elsevier Ltd All rights reserved 1403
Statistical Analyses
For proteomic experiments comparing proteome-wide interactions of several
environmental chemicals, a two-way ANOVA with Tukey’s multiple com-
parisons test was used for statistical analysis. For proteomic and metabolo-
mics analyses of in vivo CTN targets comparing vehicle with CTN treatment
in liver or kidney, we used a two-tailed t test coupled with a >2-fold differ-
ence to identify significant (p < 0.05) CTN targets or CTN-induced changes
in metabolite levels was used (Bourgon et al., 2010; McCarthy and Smyth,
2009).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Methods, three tables, and
four figures and can be found with this article online at http://dx.doi.org/10.
1016/j.chembiol.2015.09.008.
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